BioIntelliSense Funding & Investors
BioIntelliSense has enabled medical-grade Remote Patient Monitoring Hospital at Home (RPM-H@H) via its BioSticker-based data service. The BioSticker™ is an FDA-cleared 510k class II wearable medical device that enables at-home continuous monitoring of vital signs and symptoms directly associated with COVID-19 (temperature, respiratory rate at rest, and coughing frequency) for 30 days on a single device without recharging.
biointellisense.comTotal Amount Raised: $72,797,664
BioIntelliSense Funding Rounds
Grant
$2,800,000
Grant Investors
Oxford Construction of PennsylvaniaSeries A
$24,997,665
Series A Investors
Fresenius Medical CareFresenius Medical CareJonathan WeinerSeries B
$45,000,000
Series B Investors
Chimera InvestmentMary TolanJim Murren7wireVenturesPendrelliD Ventures AmericaFresenius Medical Care
Funding info provided by Diffbot.